Insights

Biotech Funding Nuclera Ltd secured significant funding with a $75 million Series C financing round led by Patient Square Capital and Elevage Medical Technologies. This injection of capital indicates a strong market interest in the company's innovative protein access system, presenting an opportunity for product expansion and increased market reach.

Rapid Protein Technology Nuclera's eProtein Discovery™ system offers automated construct screening and rapid protein scale-up within 48 hours, providing researchers with quick access to high-quality, active proteins. The speed and efficiency of this technology can be marketed as a competitive advantage, appealing to research labs seeking to accelerate their protein projects.

Key Personnel Addition Nuclera recently appointed Joseph Bertelsen, an experienced Chief Commercial Officer, to lead commercialization efforts. Bertelsen's expertise in establishing sustainable revenue streams and distribution entities can be leveraged to drive sales growth and strategic partnerships, opening doors to new market segments and collaborations.

Innovate UK Funding Nuclera received £1.14M Innovate UK funding for the development of its eProtein Discovery platform. This endorsement from a prominent innovation agency not only validates the technological prowess of the company but also presents opportunities to showcase the system's capabilities to a wider audience, potentially leading to increased sales traction.

Competitive Landscape Within the biotech sector, Nuclera competes with companies like Benchling, GenScript, and Twist Bioscience. Understanding the unique value proposition of Nuclera's protein synthesis technology compared to these competitors can aid in crafting targeted sales strategies to differentiate the company and capture market share.

Nuclera Tech Stack

Nuclera uses 8 technology products and services including Outreach.io, MySQL, Oracle Database, and more. Explore Nuclera's tech stack below.

  • Outreach.io
    Customer Relationship Management
  • MySQL
    Database
  • Oracle Database
    Database
  • Oracle
    Enterprise
  • IFS Enterprise Resource Planning
    Enterprise Resource Planning
  • jQuery Migrate
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Linkedin
    Widgets

Media & News

Nuclera's Email Address Formats

Nuclera uses at least 1 format(s):
Nuclera Email FormatsExamplePercentage
FLast@nuclera.comJDoe@nuclera.com
97%
FMiddleLast@nuclera.comJMichaelDoe@nuclera.com
1%
First@nuclera.comJohn@nuclera.com
1%
Last@nuclera.comDoe@nuclera.com
1%

Frequently Asked Questions

Where is Nuclera's headquarters located?

Minus sign iconPlus sign icon
Nuclera's main headquarters is located at One Vision Park Chivers Way, Histon Cambridge, Cambridgeshire CB24 9LF GB. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Nuclera's official website and social media links?

Minus sign iconPlus sign icon
Nuclera's official website is nuclera.com and has social profiles on LinkedIn.

How much revenue does Nuclera generate?

Minus sign iconPlus sign icon
As of November 2024, Nuclera's annual revenue reached $15M.

What is Nuclera's SIC code NAICS code?

Minus sign iconPlus sign icon
Nuclera's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nuclera have currently?

Minus sign iconPlus sign icon
As of November 2024, Nuclera has approximately 131 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Commercial Officer (cco): J. B.Chief Information Security Officer: A. Z.Vice President Intellectual Property: C. B.. Explore Nuclera's employee directory with LeadIQ.

What industry does Nuclera belong to?

Minus sign iconPlus sign icon
Nuclera operates in the Biotechnology Research industry.

What technology does Nuclera use?

Minus sign iconPlus sign icon
Nuclera's tech stack includes Outreach.ioMySQLOracle DatabaseOracleIFS Enterprise Resource PlanningjQuery MigrateMicrosoftLinkedin.

What is Nuclera's email format?

Minus sign iconPlus sign icon
Nuclera's email format typically follows the pattern of . Find more Nuclera email formats with LeadIQ.

How much funding has Nuclera raised to date?

Minus sign iconPlus sign icon
As of November 2024, Nuclera has raised $75M in funding. The last funding round occurred on Oct 15, 2024 for $75M.

When was Nuclera founded?

Minus sign iconPlus sign icon
Nuclera was founded in 2013.
Nuclera

Nuclera

Biotechnology ResearchCambridgeshire, United Kingdom51-200 Employees

At Nuclera, our mission is to better human health by making proteins accessible.  We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster.

Our eProtein Discovery™ system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours.  From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours.  Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, allowing rapid progress on protein projects through a benchtop, automated, high-throughput protein access system.

Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.

Section iconCompany Overview

Headquarters
One Vision Park Chivers Way, Histon Cambridge, Cambridgeshire CB24 9LF GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $75M

    Nuclera has raised a total of $75M of funding over 11 rounds. Their latest funding round was raised on Oct 15, 2024 in the amount of $75M.

  • $10M$50M

    Nuclera's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $75M

    Nuclera has raised a total of $75M of funding over 11 rounds. Their latest funding round was raised on Oct 15, 2024 in the amount of $75M.

  • $10M$50M

    Nuclera's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.